Alnylam Pharmaceuticals
Ann DiBiase is an accomplished professional in the pharmaceutical and biotechnology industries with extensive experience in commercial training, marketing, and operational strategies. Currently serving as VP and Head of US Commercial Training & Operations at Alnylam Pharmaceuticals, Ann has held various leadership positions, including Sr. Director roles in training and development. Prior experience includes significant contributions at bluebird bio, Boston Heart Diagnostics, Sunovion Pharmaceuticals, Alkermes, and Cephalon, where responsibilities ranged from developing training programs to spearheading marketing strategies for products like VIVITROL. Ann holds an MBA from Boston University and a BS from Cornell University, demonstrating a strong educational foundation in business and biology.
This person is not in the org chart
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.